Compendium of Cancer Genome Aberrations

Changes

SKIN5:Volunteer Assignments and Opportunities (view source)

Revision as of 16:44, 26 January 2024

25,397 bytes added ,  16:44, 26 January 2024
no edit summary
Line 6: Line 6:     
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 +
<br />
 
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
 
|+<big>WHO Classification of Skin Tumours (5th Edition) Content</big>
 
|+<big>WHO Classification of Skin Tumours (5th Edition) Content</big>
Line 17: Line 18:  
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
 +
|CHAPTER 2 (KERATINOCYTIC/EPIDERMAL TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[SKIN5:Actinic_keratosis|Actinic keratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Arsenical_keratosis|Arsenical keratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:PUVA_keratosis|PUVA keratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Squamous_cell_carcinoma_in_situ_(Bowen_disease)|Squamous cell carcinoma in situ (Bowen disease)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Verruca_vulgaris|Verruca vulgaris]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Verruca_plantaris_and_palmaris|Verruca plantaris and palmaris]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Verruca_plana|Verruca plana]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Seborrhoeic_keratosis|Seborrhoeic keratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Solar_lentigo|Solar lentigo]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Lichen_planus-like_keratosis|Lichen planus-like keratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Clear_cell_acanthoma|Clear cell acanthoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Large_cell_acanthoma|Large cell acanthoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Warty_dyskeratoma|Warty dyskeratoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Other_benign_keratoses|Other benign keratoses]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Basal_cell_carcinomas|Basal cell carcinomas]]
 +
|Disease (OVERVIEW?)
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Superficial_basal_cell_carcinoma|Superficial basal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Nodular_basal_cell_carcinoma|Nodular basal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Micronodular_basal_cell_carcinoma|Micronodular basal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Infiltrating_basal_cell_carcinoma|Infiltrating basal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Sclerosing/morphoeic_basal_cell_carcinoma|Sclerosing/morphoeic basal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Basosquamous_carcinoma|Basosquamous carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Basal_cell_carcinoma_with_sarcomatoid_differentiation|Basal cell carcinoma with sarcomatoid differentiation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Basal_cell_carcinoma_with_adnexal_differentiation|Basal cell carcinoma with adnexal differentiation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Fibroepithelial_basal_cell_carcinoma|Fibroepithelial basal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Keratoacanthoma|Keratoacanthoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Squamous_cell_carcinomas|Squamous cell carcinomas]]
 +
|Disease (OVERVIEW?)
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Verrucous_squamous_cell_carcinoma|Verrucous squamous cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 27: Line 335:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Acantholytic_squamous_cell_carcinoma|Acantholytic squamous cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 36: Line 346:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Lymphoepithelial_carcinoma|Lymphoepithelial carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 45: Line 357:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Clear_cell_squamous_cell_carcinoma|Clear cell squamous cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 54: Line 368:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Spindle_cell_squamous_cell_carcinoma|Spindle cell squamous cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 63: Line 379:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Squamous_cell_carcinoma_with_sarcomatoid_differentiation|Squamous cell carcinoma with sarcomatoid differentiation]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 72: Line 390:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Merkel_cell_carcinoma|Merkel cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 81: Line 401:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 3 (MELANOCYTIC TUMOURS)
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Junctional,_compound,_and_dermal_naevi|Junctional, compound, and dermal naevi]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 99: Line 432:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Simple_lentigo_and_lentiginous_melanocytic_naevus|Simple lentigo and lentiginous melanocytic naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 108: Line 443:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Dysplastic_naevus|Dysplastic naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 117: Line 454:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Naevus_spilus|Naevus spilus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 126: Line 465:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Special-site_naevi_(of_the_breast,_axilla,_scalp,_and_ear)|Special-site naevi (of the breast, axilla, scalp, and ear)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 135: Line 476:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Halo_naevus|Halo naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 144: Line 487:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Meyerson_naevus|Meyerson naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 153: Line 498:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Recurrent_naevus|Recurrent naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 162: Line 509:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Combined_naevus|Combined naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 171: Line 520:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:WNT-activated_deep_penetrating/plexiform_melanocytoma_(naevus)|WNT-activated deep penetrating/plexiform melanocytoma (naevus)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 180: Line 531:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Pigmented_epithelioid_melanocytoma|Pigmented epithelioid melanocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 189: Line 542:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:BAP1-inactivated_melanocytoma|BAP1-inactivated melanocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 198: Line 553:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:MITF_pathway-activated_melanocytic_tumours|MITF pathway-activated melanocytic tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 207: Line 564:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Low-CSD_melanoma_(including_superficial_spreading_melanoma)|Low-CSD melanoma (including superficial spreading melanoma)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 216: Line 575:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Lentigo_maligna_melanoma|Lentigo maligna melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Desmoplastic_melanoma|Desmoplastic melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Pigmented_spindle_cell_naevus_(Reed_naevus)|Pigmented spindle cell naevus (Reed naevus)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Spitz_naevus|Spitz naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 225: Line 619:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Spitz_melanocytoma_(Atypical_Spitz_tumour)|Spitz melanocytoma (Atypical Spitz tumour)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 234: Line 630:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Spitz_melanoma|Spitz melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 243: Line 641:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Acral_naevus|Acral naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 252: Line 652:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Acral_melanoma|Acral melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 261: Line 663:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Melanosis|Melanosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 270: Line 674:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Genital_naevus|Genital naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 279: Line 685:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Mucosal_melanomas|Mucosal melanomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 288: Line 696:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Naevus_of_Ito_and_naevus_of_Ota|Naevus of Ito and naevus of Ota]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 297: Line 707:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Congenital_dermal_melanocytosis|Congenital dermal melanocytosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 306: Line 718:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Blue_naevus|Blue naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 315: Line 729:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Melanoma_arising_in_blue_naevus|Melanoma arising in blue naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 324: Line 740:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Congenital_melanocytic_naevus|Congenital melanocytic naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 333: Line 751:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Proliferative_nodules_in_congenital_melanocytic_naevus|Proliferative nodules in congenital melanocytic naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 342: Line 762:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Melanoma_arising_in_giant_congenital_naevus|Melanoma arising in giant congenital naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 351: Line 773:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Conjunctival_naevus|Conjunctival naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 360: Line 784:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Conjunctival_melanocytic_intraepithelial_lesions|Conjunctival melanocytic intraepithelial lesions]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 369: Line 795:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Conjunctival_melanoma|Conjunctival melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 378: Line 806:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Uveal_melanocytoma|Uveal melanocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 387: Line 817:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Uveal_melanoma|Uveal melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 396: Line 828:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Diffuse_meningeal_melanocytic_neoplasms:_melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: melanocytosis and melanomatosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 405: Line 839:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Circumscribed_meningeal_melanocytic_neoplasms:_melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: melanocytoma and melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 414: Line 850:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Nodular_melanoma|Nodular melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 423: Line 861:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Naevoid_melanoma|Naevoid melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 432: Line 872:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Dermal_melanoma|Dermal melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 441: Line 883:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Melanoma_metastatic_to_the_skin|Melanoma metastatic to the skin]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 450: Line 894:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Melanoma_metastatic_to_other_organs|Melanoma metastatic to other organs]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 459: Line 905:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 4 (APPENDAGEAL TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Hidrocystoma/cystadenoma|Hidrocystoma/cystadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 477: Line 936:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Syringoma|Syringoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 486: Line 947:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Poroma|Poroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 495: Line 958:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Syringofibroadenoma|Syringofibroadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 504: Line 969:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Hidradenoma|Hidradenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 513: Line 980:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Spiradenoma|Spiradenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 522: Line 991:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Cylindroma|Cylindroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 531: Line 1,002:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Tubular_adenoma|Tubular adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 540: Line 1,013:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Syringocystadenoma_papilliferum|Syringocystadenoma papilliferum]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 549: Line 1,024:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Mixed_tumour|Mixed tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 558: Line 1,035:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Myoepithelioma|Myoepithelioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 567: Line 1,046:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Adnexal_adenocarcinoma,_NOS|Adnexal adenocarcinoma, NOS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 576: Line 1,057:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Microcystic_adnexal_carcinoma|Microcystic adnexal carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 585: Line 1,068:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Cribriform_tumour_(previously_carcinoma)|Cribriform tumour (previously carcinoma)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 594: Line 1,079:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Porocarcinoma|Porocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 603: Line 1,090:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:NUT_carcinoma|NUT carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 612: Line 1,101:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Malignant_neoplasms_arising_from_spiradenoma,_cylindroma,_or_spiradenocylindroma|Malignant neoplasms arising from spiradenoma, cylindroma, or spiradenocylindroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 621: Line 1,112:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Malignant_mixed_tumour|Malignant mixed tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 630: Line 1,123:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Hidradenocarcinoma|Hidradenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 639: Line 1,134:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Endocrine_mucin-producing_sweat_gland_carcinoma|Endocrine mucin-producing sweat gland carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 648: Line 1,145:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Mucinous_carcinoma|Mucinous carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 657: Line 1,156:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Digital_papillary_adenocarcinoma|Digital papillary adenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 666: Line 1,167:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 675: Line 1,178:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Apocrine_carcinoma|Apocrine carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 684: Line 1,189:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Squamoid_ductal_eccrine_carcinoma|Squamoid ductal eccrine carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 693: Line 1,200:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Syringocystadenocarcinoma_papilliferum|Syringocystadenocarcinoma papilliferum]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 702: Line 1,211:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Secretory_carcinoma|Secretory carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 711: Line 1,222:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Signet-ring_cell/histiocytoid_carcinoma|Signet-ring cell/histiocytoid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 720: Line 1,233:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Trichoblastoma|Trichoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 729: Line 1,244:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Pilomatricoma|Pilomatricoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 738: Line 1,255:  
|
 
|
 
|-
 
|-
 +
|[[SKIN5:Melanocytic_matricoma|Melanocytic matricoma]]
 +
|Disease
 
|
 
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Trichilemmoma|Trichilemmoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Trichoadenoma|Trichoadenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Trichofolliculoma|Trichofolliculoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Pilar_sheath_acanthoma|Pilar sheath acanthoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Tumour_of_the_follicular_infundibulum|Tumour of the follicular infundibulum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Trichodiscomas_and_fibrofolliculomas|Trichodiscomas and fibrofolliculomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Proliferating_trichilemmal_tumour|Proliferating trichilemmal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Pilomatrical_carcinoma|Pilomatrical carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Trichoblastic_carcinoma/carcinosarcoma|Trichoblastic carcinoma/carcinosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Trichilemmal_carcinoma|Trichilemmal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Sebaceoma|Sebaceoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Sebaceous_adenoma|Sebaceous adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Sebaceous_carcinoma|Sebaceous carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Hidradenoma_papilliferum|Hidradenoma papilliferum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Fibroadenoma_and_phyllodes_tumour_of_anogenital_mammary-like_glands|Fibroadenoma and phyllodes tumour of anogenital mammary-like glands]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Mammary_Paget_disease|Mammary Paget disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Extramammary_Paget_disease|Extramammary Paget disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Adenocarcinoma_of_mammary-gland_type|Adenocarcinoma of mammary-gland type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 5 (TUMOURS OF THE NAIL UNIT)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[SKIN5:Onychomatricoma|Onychomatricoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Onychopapilloma|Onychopapilloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Ungual_fibrokeratoma|Ungual fibrokeratoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Onychocytic_matricoma|Onychocytic matricoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Subungual_keratoacathoma|Subungual keratoacathoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 6 (TUMOURS OF HAEMATOPOIETIC AND LYMPHOID ORIGIN)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[SKIN5:Mastocytosis|Mastocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Mast_cell_sarcoma|Mast cell sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Cutaneous_involvement_in_myeloid_neoplasms,_including_myeloid_sarcoma|Cutaneous involvement in myeloid neoplasms, including myeloid sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Mature_plasmacytoid_dendritic_cell_proliferation_associated_with_myeloid_neoplasm|Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Blastic_plasmacytoid_dendritic_cell_neoplasm|Blastic plasmacytoid dendritic cell neoplasm]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Xanthelasma|Xanthelasma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Reticulohistiocytosis|Reticulohistiocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Rosai-Dorfman_Disease|Rosai-Dorfman Disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:ALK_postive_histiocytosis_|ALK postive histiocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Histiocytic_sarcoma|Histiocytic sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Indeterminate_dendritic_cell_tumour|Indeterminate dendritic cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Reactive_B-cell_rich_lymphoid_proliferations|Reactive B-cell rich lymphoid proliferations]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_marginal_zone_lymphoma|Primary cutaneous marginal zone lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_follicle_centre_lymphoma|Primary cutaneous follicle centre lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_diffuse_large_B-cell_lymphoma,_leg_type|Primary cutaneous diffuse large B-cell lymphoma, leg type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Mantle_cell_lymphoma|Mantle cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Burkitt_lymphoma|Burkitt lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Chronic_lymphocytic_leukaemia/small_lymphocytic_lymphoma|Chronic lymphocytic leukaemia/small lymphocytic lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:B-lymphoblastic_leukaemia/lymphoma|B-lymphoblastic leukaemia/lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Secondary_lymphomatoid_granulomatosis_|Secondary lymphomatoid granulomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Reactive_T-cell_rich_lymphoid_proliferations|Reactive T-cell rich lymphoid proliferations]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_CD4-positive_small_or_medium_T-cell_lymphoproliferative_disorder|Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Mycosis_fungoides|Mycosis fungoides]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_CD30+_T-cell_lymphoproliferative_disorder:_Lymphomatoid_papulosis|Primary cutaneous CD30+ T-cell lymphoproliferative disorder: Lymphomatoid papulosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_CD30+_T-cell_lymphoproliferative_disorder:_Primary_cutaneous_anaplastic_large_cell_lymphoma|Primary cutaneous CD30+ T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Subcutaneous_panniculitis-like_T-cell_lymphoma|Subcutaneous panniculitis-like T-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_gamma/delta_T-cell_lymphoma|Primary cutaneous gamma/delta T-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_acral_CD8-positive_T-cell_lymphoproliferative_disorder|Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_CD8-positive_aggressive_epidermotropic_cytotoxic_T-cell_lymphoma|Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_peripheral_T-cell_lymphoma,_NOS|Primary cutaneous peripheral T-cell lymphoma, NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Sezary_syndrome|Sezary syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Severe_mosquito_bite_allergy|Severe mosquito bite allergy]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Hydroa_vacciniforme_lymphoproliferative_disorder|Hydroa vacciniforme lymphoproliferative disorder]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Anaplastic_large_cell_lymphoma|Anaplastic large cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Nodal_T_follicular_helper_lymphoma,_angioimmunoblastic_type|Nodal T follicular helper lymphoma, angioimmunoblastic type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:T-cell_prolymphocytic_leukaemia|T-cell prolymphocytic leukaemia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:T-lymphoblastic_leukaemia/lymphoma|T-lymphoblastic leukaemia/lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Adult_T_cell_leukaemia/lymphoma|Adult T cell leukaemia/lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Extranodal_NK/T-cell_lymphoma|Extranodal NK/T-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:EBV-positive_mucocutaneous_ulcer|EBV-positive mucocutaneous ulcer]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Inborn_error_of_immunity-associated_lymphoproliferative_disorders|Inborn error of immunity-associated lymphoproliferative disorders]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 7 (SOFT TISSUE TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[SKIN5:Naevus_lipomatosus_superficialis|Naevus lipomatosus superficialis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Lipoma|Lipoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Angiolipoma|Angiolipoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Spindle_cell/pleomorphic_lipoma|Spindle cell/pleomorphic lipoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Atypical_lipomatous_tumour|Atypical lipomatous tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Pleomorphic_liposarcoma|Pleomorphic liposarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Sclerotic_fibroma|Sclerotic fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Nuchal-type_fibroma|Nuchal-type fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Gardner_fibroma|Gardner fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Pleomorphic_fibroma|Pleomorphic fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Elastofibroma|Elastofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Fibrous_papule|Fibrous papule]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Fibroblastic_connective_tissue_naevus|Fibroblastic connective tissue naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Fibroosseous_tumour_of_digits|Fibroosseous tumour of digits]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Dermatofibroma_(fibrous_histiocytoma)|Dermatofibroma (fibrous histiocytoma)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Superficial_fibromatosis|Superficial fibromatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Inclusion_body_fibromatosis_|Inclusion body fibromatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Superficial_acral_fibromyxoma|Superficial acral fibromyxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Cutaneous_myxoma_(superficial_angiomyxoma)|Cutaneous myxoma (superficial angiomyxoma)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Dermatomyofibroma|Dermatomyofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Multinucleate_cell_angiohistiocytoma|Multinucleate cell angiohistiocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Plaque-like_CD34+_dermal_fibroma|Plaque-like CD34+ dermal fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Nodular_fasciitis|Nodular fasciitis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:EWSR1::SMAD3_rearranged_fibroblastic_tumour|EWSR1::SMAD3 rearranged fibroblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Myxofibrosarcoma|Myxofibrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Cherry_haemangioma|Cherry haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Sinusoidal_haemangioma|Sinusoidal haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Microvenular_haemangioma|Microvenular haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Hobnail_haemangioma|Hobnail haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Glomeruloid_haemangioma|Glomeruloid haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Papillary_haemangioma|Papillary haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Spindle_cell_haemangioma|Spindle cell haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Epithelioid_haemangioma|Epithelioid haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Tufted_haemangioma|Tufted haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Angiokeratoma|Angiokeratoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Infantile_haemangioma|Infantile haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Congenital_non-progressive_haemangiomas:_rapidly_involuting_congenital_haemangioma_and_non-involuting_congenital_haemangioma|Congenital non-progressive haemangiomas: rapidly involuting congenital haemangioma and non-involuting congenital haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Lobular_capillary_haemangioma|Lobular capillary haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Poikilodermatous_plaque-like_haemangioma|Poikilodermatous plaque-like haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Acquired_elastotic_haemangioma|Acquired elastotic haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Verrucous_venous_malformation|Verrucous venous malformation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Arteriovenous_malformation|Arteriovenous malformation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Lymphangioma_(superficial_lymphatic_malformation)|Lymphangioma (superficial lymphatic malformation)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Cutaneous_epithelioid_angiomatous_nodule|Cutaneous epithelioid angiomatous nodule]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Post-radiation_atypical_vascular_lesion|Post-radiation atypical vascular lesion]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Hobnail_haemangioendotheliomas|Hobnail haemangioendotheliomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Kaposi_sarcoma|Kaposi sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Cutaneous_angiosarcoma|Cutaneous angiosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Glomus_tumour|Glomus tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Myopericytoma|Myopericytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Myofibroma_and_myofibromatosis|Myofibroma and myofibromatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Angioleiomyoma|Angioleiomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Smooth_muscle_hamartoma|Smooth muscle hamartoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Cutaneous_leiomyomas|Cutaneous leiomyomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Atypical_intradermal_smooth_muscle_neoplasm|Atypical intradermal smooth muscle neoplasm]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Dermal_hyperneury/Epithelial_sheath_neuroma|Dermal hyperneury/Epithelial sheath neuroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Perineurioma|Perineurioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Neurofibroma|Neurofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Schwannoma|Schwannoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Granular_cell_tumour|Granular cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Hybrid_nerve_sheath_tumours_|Hybrid nerve sheath tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Cellular_neurothekeoma|Cellular neurothekeoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Epithelioid_fibrous_histiocytoma|Epithelioid fibrous histiocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Non-neural_granular_cell_tumour|Non-neural granular cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:PEComa_|PEComa]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Angiomatoid_fibrous_histiocytoma_|Angiomatoid fibrous histiocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:NTRK-rearranged_spindle_cell_neoplasm|NTRK-rearranged spindle cell neoplasm]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Superficial_CD34+_fibroblastic_tumour|Superficial CD34+ fibroblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Pleomorphic_dermal_sarcoma|Pleomorphic dermal sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Epithelioid_sarcoma|Epithelioid sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:CRTC1::TRIM11_cutaneous_tumour|CRTC1::TRIM11 cutaneous tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Dermal_clear_cell_sarcoma|Dermal clear cell sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Ewing_sarcoma|Ewing sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 8 (METASTASES TO SKIN)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[SKIN5:Metastases_to_skin|Metastases to skin]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Cancer_of_unknown_primary_site|Cancer of unknown primary site]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 9 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH SKIN  MALIGNANCIES)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[SKIN5:Familial_melanoma|Familial melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Xeroderma_pigmentosum|Xeroderma pigmentosum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Naevoid_basal_cell_carcinoma_syndrome_(Gorlin_syndrome)|Naevoid basal cell carcinoma syndrome (Gorlin syndrome)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Carney_complex|Carney complex]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Muir-Torre_syndrome|Muir-Torre syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Brooke-Spiegler_and_related_syndromes|Brooke-Spiegler and related syndromes]]
 
|Disease
 
|Disease
 
|
 
|
Retrieved from "https://content.ccga.io/index.php/Special:MobileDiff/14128"